PKU HealthCare Corp Ltd
SZSE:000788
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
PKU HealthCare Corp Ltd
Revenue
PKU HealthCare Corp Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
PKU HealthCare Corp Ltd
SZSE:000788
|
Revenue
¥1.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-2%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥15B
|
CAGR 3-Years
17%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥32.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥41.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Revenue
¥22.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Revenue
¥2.5B
|
CAGR 3-Years
53%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
PKU HealthCare Corp Ltd
Glance View
PKU Healthcare Corp., Ltd. engages in the research, development, production and sale of chemical-pharmaceutical preparations. The company is headquartered in Chongqing, Chongqing and currently employs 783 full-time employees. The firm is also engaged in the pharmaceutical distribution business and the provision of related medical services. The firm's main pharmaceutical preparations include digestive, cardiovascular, endocrine, anti-infective, central nervous, analgesic and other preparations. The firm mainly conducts its business in domestic market.
See Also
What is PKU HealthCare Corp Ltd's Revenue?
Revenue
1.8B
CNY
Based on the financial report for Sep 30, 2025, PKU HealthCare Corp Ltd's Revenue amounts to 1.8B CNY.
What is PKU HealthCare Corp Ltd's Revenue growth rate?
Revenue CAGR 10Y
-2%
Over the last year, the Revenue growth was -15%. The average annual Revenue growth rates for PKU HealthCare Corp Ltd have been -6% over the past three years , -4% over the past five years , and -2% over the past ten years .
